Skip to main content
. 2014 Oct 1;9(10):e109034. doi: 10.1371/journal.pone.0109034

Figure 4. Late administration of MSC post-BMT reduces manifestations of OB.

Figure 4

Starting at 4 weeks post-BMT, MSCs were administered IV every 1, 2 or 3 weeks until day 90. A. Inspiratory Capacity; B. Resistance; C. Compliance; D. OH-proline. Significant differences are indicated on graph. N = 6–14/group pooled from 2 experiments. LFs = mouse lung fibroblasts used as control cells.